Neurology Central

Pacifying pain: mouse study reveals a gene-therapy approach could be used to relieve chronic pain


Researchers at Navega Therapeutics (CA, USA) have revealed that CRISPR, a gene-editing technique, could potentially be used to treat individuals with chronic pain. This follows a study applying the novel technique on mice administered with chemotherapy, known to commonly cause pain in cancer patients. Should the method be translated to humans and the treatment demonstrated to be safe, it could potentially provide an alternative to opioids. 

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.